Menu

French Scientists Petition for Firm Stance Against Springer

More than 2,000 signatories urge a national consortium of French academic institutions to refuse an increase in journal subscription fees.

Apr 11, 2018
Diana Kwon

ISTOCK, LEREMYA group of researchers at the French National Center for Scientific Research (CNRS) started an online petition last weekend (April 8) to publically support Couperin.org, a national consortium representing more than 250 academic institutions in France, in its fee negotiations with academic publisher SpringerNature. More than 2,000 people have signed the petition so far.

“We are employed by the institutions members of Couperin. As such, our work will be directly affected should Springer eventually decide to enact their decision and shut down access to their recent contents,” the petition states. “However, we support the firm stance taken by Couperin and we are ready to endure this relative discomfort for as long as it will be necessary to bring Springer to acceptable propositions.”

See “French Universities Cancel Subscriptions to Springer Journals” 

Fee negotiations between Couperin.org and SpringerNature regarding one of the publisher’s platforms, Springer—which alone has more than 2,000 journals—are stuck in a stalemate. The key point of contention is a rise in subscription costs, which the consortium believes should be reduced in light of the rising proportion of expensive open-access papers.

Last month, the consortium announced that French universities and research organizations would not renew their Springer subscriptions due to this disagreement.

The publisher told The Scientist last month that it would maintain institutions’ access to its journals while in negotiations. If that agreements ends, French scientists are willing to deal with the repercussions. “No more direct access to Springer’s latest papers? No problem,” the petition states. “There are so many ways [to access papers]: institutional depositories, social networks, direct requests to the authors… We are not worried.”

April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Marketplace

Sponsored Product Updates

Getting More Consistent Results by Knowing the Quality of Your Protein
Getting More Consistent Results by Knowing the Quality of Your Protein
Download this guide from NanoTemper to learn how to identify and evaluate the quality of your protein samples!
Myth Busting: The Best Way to Use Pure Water in the Lab
Myth Busting: The Best Way to Use Pure Water in the Lab
Download this white paper from ELGA LabWater to learn about the role of pure water in the laboratory and the advantages of in-house water purification!
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu Corporation announces the release of the Nexera Ultra High-Performance Liquid Chromatograph series, incorporating artificial intelligence as Analytical Intelligence, allowing systems to detect and resolve issues automatically. The Nexera series makes lab management simple by integrating IoT and device networking, enabling users to easily review instrument status, optimize resource allocation, and achieve higher throughput.
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
Increasing accuracy and reducing cost barriers, IDT’s innovative system delivers simple and cost-effective amplicon sequencing